BLOOD-BASED EXOSOMAL ALPHA-SYNUCLEIN AGGREGATES AS A QUANTIFIABLE BIOMARKER OF PARKINSON'S DISEASE. NEW AWARD.

University Of Washington, Seattle WA

Investigators